During tumour evolution, high levels of MYC expression can result in increased expression of PD-L1 by direct binding to its promoter [112], as well as by hijacking the phospho-eIF2a dependent adaptive stress pathway to bypass the post-transcriptional control orchestrated at the 5′-UTR of the PD-L1 mRNA [113]. The gene discussed is CD274; the disease is neoplasm.